Skip to main content
Erschienen in: Abdominal Radiology 2/2017

12.01.2017 | Invited Article

Celiac disease: a clinical review

verfasst von: Badr Al-Bawardy, D. Chamil Codipilly, Alberto Rubio-Tapia, David H. Bruining, Stephanie L. Hansel, Joseph A. Murray

Erschienen in: Abdominal Radiology | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Celiac disease (CD) is an immune-mediated inflammatory enteropathy triggered by gluten exposure in genetically susceptible individuals. It has a high prevalence approaching 1% of the US population. A high index of suspicion is warranted to diagnose CD as frequently patients present with extraintestinal or atypical manifestations. CD is diagnosed by a combination of serum serologies and duodenal biopsies. The majority of patients will respond to a lifelong gluten-free diet which is the cornerstone of therapy. Complications such as refractory CD, ulcerative jejunoileitis, enteropathy associated T-cell lymphoma and small bowel adenocarcinoma occur in a minority of patients.
Literatur
1.
Zurück zum Zitat Fasano A, Berti I, Gerarduzzi T, et al. (2003) Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 163(3):286–292PubMedCrossRef Fasano A, Berti I, Gerarduzzi T, et al. (2003) Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 163(3):286–292PubMedCrossRef
3.
Zurück zum Zitat Kim HS, Patel KG, Orosz E, et al. (2016) Time trends in the prevalence of celiac disease and gluten-free diet in the US population: results from the National Health and Nutrition Examination surveys 2009–2014. JAMA Intern Med 176(111):1716–1717PubMedCrossRef Kim HS, Patel KG, Orosz E, et al. (2016) Time trends in the prevalence of celiac disease and gluten-free diet in the US population: results from the National Health and Nutrition Examination surveys 2009–2014. JAMA Intern Med 176(111):1716–1717PubMedCrossRef
4.
Zurück zum Zitat Choung RS, Ditah IC, Nadeau AM, et al. (2015) Trends and racial/ethnic disparities in gluten-sensitive problems in the United States: findings from the National Health and Nutrition Examination Surveys from 1988 to 2012. Am J Gastroenterol 110(3):455–461. doi:10.1038/ajg.2015.8 PubMedCrossRef Choung RS, Ditah IC, Nadeau AM, et al. (2015) Trends and racial/ethnic disparities in gluten-sensitive problems in the United States: findings from the National Health and Nutrition Examination Surveys from 1988 to 2012. Am J Gastroenterol 110(3):455–461. doi:10.​1038/​ajg.​2015.​8 PubMedCrossRef
5.
Zurück zum Zitat Tommasini A, Not T, Kiren V, et al. (2004) Mass screening for coeliac disease using antihuman transglutaminase antibody assay. Arch Dis Child 89(6):512–515PubMedPubMedCentralCrossRef Tommasini A, Not T, Kiren V, et al. (2004) Mass screening for coeliac disease using antihuman transglutaminase antibody assay. Arch Dis Child 89(6):512–515PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Catassi C, Fanciulli G, D’Appello AR, et al. (2000) Antiendomysium versus antigliadin antibodies in screening the general population for coeliac disease. Scand J Gastroenterol 35(7):732–736PubMedCrossRef Catassi C, Fanciulli G, D’Appello AR, et al. (2000) Antiendomysium versus antigliadin antibodies in screening the general population for coeliac disease. Scand J Gastroenterol 35(7):732–736PubMedCrossRef
7.
Zurück zum Zitat Trevisiol C, Not T, Berti I, et al. (1999) Screening for coeliac disease in healthy blood donors at two immuno-transfusion centres in north-east Italy. Ital J Gastroenterol Hepatol 31(7):584–586PubMed Trevisiol C, Not T, Berti I, et al. (1999) Screening for coeliac disease in healthy blood donors at two immuno-transfusion centres in north-east Italy. Ital J Gastroenterol Hepatol 31(7):584–586PubMed
8.
Zurück zum Zitat Volta U, Bellentani S, Bianchi FB, et al. (2001) High prevalence of celiac disease in Italian general population. Dig Dis Sci 46(7):1500–1505PubMedCrossRef Volta U, Bellentani S, Bianchi FB, et al. (2001) High prevalence of celiac disease in Italian general population. Dig Dis Sci 46(7):1500–1505PubMedCrossRef
9.
Zurück zum Zitat West J, Logan RF, Hill PG, et al. (2003) Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut 52(7):960–965PubMedPubMedCentralCrossRef West J, Logan RF, Hill PG, et al. (2003) Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut 52(7):960–965PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Carlsson AK, Axelsson IE, Borulf SK, Bredberg AC, Ivarsson SA (2001) Serological screening for celiac disease in healthy 2.5-year-old children in Sweden. Pediatrics 107(1):42–45PubMedCrossRef Carlsson AK, Axelsson IE, Borulf SK, Bredberg AC, Ivarsson SA (2001) Serological screening for celiac disease in healthy 2.5-year-old children in Sweden. Pediatrics 107(1):42–45PubMedCrossRef
12.
Zurück zum Zitat Kolho KL, Farkkila MA, Savilahti E (1998) Undiagnosed coeliac disease is common in Finnish adults. Scand J Gastroenterol 33(12):1280–1283PubMedCrossRef Kolho KL, Farkkila MA, Savilahti E (1998) Undiagnosed coeliac disease is common in Finnish adults. Scand J Gastroenterol 33(12):1280–1283PubMedCrossRef
15.
Zurück zum Zitat Catassi C, Ratsch IM, Gandolfi L, et al. (1999) Why is coeliac disease endemic in the people of the Sahara? Lancet (London, England) 354(9179):647–648CrossRef Catassi C, Ratsch IM, Gandolfi L, et al. (1999) Why is coeliac disease endemic in the people of the Sahara? Lancet (London, England) 354(9179):647–648CrossRef
16.
Zurück zum Zitat Barada K, Bitar A, Mokadem MA, Hashash JG, Green P (2010) Celiac disease in Middle Eastern and North African countries: a new burden? World J Gastroenterol 16(12):1449–1457PubMedPubMedCentralCrossRef Barada K, Bitar A, Mokadem MA, Hashash JG, Green P (2010) Celiac disease in Middle Eastern and North African countries: a new burden? World J Gastroenterol 16(12):1449–1457PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Rewers M (2005) Epidemiology of celiac disease: what are the prevalence, incidence, and progression of celiac disease? Gastroenterology 128(4 Suppl 1):S47–S51PubMedCrossRef Rewers M (2005) Epidemiology of celiac disease: what are the prevalence, incidence, and progression of celiac disease? Gastroenterology 128(4 Suppl 1):S47–S51PubMedCrossRef
19.
Zurück zum Zitat Abadie V, Sollid LM, Barreiro LB, Jabri B (2011) Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annu Rev Immunol 29:493–525PubMedCrossRef Abadie V, Sollid LM, Barreiro LB, Jabri B (2011) Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annu Rev Immunol 29:493–525PubMedCrossRef
21.
27.
Zurück zum Zitat Ploski R, Ek J, Thorsby E, Sollid LM (1993) On the HLA-DQ(alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. Tissue Antigens 41(4):173–177PubMedCrossRef Ploski R, Ek J, Thorsby E, Sollid LM (1993) On the HLA-DQ(alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. Tissue Antigens 41(4):173–177PubMedCrossRef
30.
Zurück zum Zitat Karell K, Louka AS, Moodie SJ, et al. (2003) HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol 64(4):469–477PubMedCrossRef Karell K, Louka AS, Moodie SJ, et al. (2003) HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol 64(4):469–477PubMedCrossRef
31.
Zurück zum Zitat Hadithi M, von Blomberg BM, Crusius JB, et al. (2007) Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease. Ann Intern Med 147(5):294–302PubMedCrossRef Hadithi M, von Blomberg BM, Crusius JB, et al. (2007) Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease. Ann Intern Med 147(5):294–302PubMedCrossRef
33.
Zurück zum Zitat Sollid LM, Thorsby E (1990) The primary association of celiac disease to a given HLA-DQ alpha/beta heterodimer explains the divergent HLA-DR associations observed in various Caucasian populations. Tissue Antigens 36(3):136–137PubMedCrossRef Sollid LM, Thorsby E (1990) The primary association of celiac disease to a given HLA-DQ alpha/beta heterodimer explains the divergent HLA-DR associations observed in various Caucasian populations. Tissue Antigens 36(3):136–137PubMedCrossRef
36.
Zurück zum Zitat Vriezinga SL, Auricchio R, Bravi E, et al. (2014) Randomized feeding intervention in infants at high risk for celiac disease. N Engl J Med 371(14):1304–1315PubMedCrossRef Vriezinga SL, Auricchio R, Bravi E, et al. (2014) Randomized feeding intervention in infants at high risk for celiac disease. N Engl J Med 371(14):1304–1315PubMedCrossRef
37.
Zurück zum Zitat Lionetti E, Castellaneta S, Francavilla R, et al. (2014) Introduction of gluten, HLA status, and the risk of celiac disease in children. N Engl J Med 371(14):1295–1303PubMedCrossRef Lionetti E, Castellaneta S, Francavilla R, et al. (2014) Introduction of gluten, HLA status, and the risk of celiac disease in children. N Engl J Med 371(14):1295–1303PubMedCrossRef
38.
Zurück zum Zitat Andren Aronsson C, Lee HS, Koletzko S, et al. (2016) Effects of gluten intake on risk of celiac disease: a case–control study on a Swedish Birth cohort. Clin Gastroenterol Hepatol 14(3):403–409PubMedCrossRef Andren Aronsson C, Lee HS, Koletzko S, et al. (2016) Effects of gluten intake on risk of celiac disease: a case–control study on a Swedish Birth cohort. Clin Gastroenterol Hepatol 14(3):403–409PubMedCrossRef
39.
Zurück zum Zitat Marild K, Stephansson O, Montgomery S, Murray JA, Ludvigsson JF (2012) Pregnancy outcome and risk of celiac disease in offspring: a nationwide case–control study. Gastroenterology 142(1):39–45PubMedCrossRef Marild K, Stephansson O, Montgomery S, Murray JA, Ludvigsson JF (2012) Pregnancy outcome and risk of celiac disease in offspring: a nationwide case–control study. Gastroenterology 142(1):39–45PubMedCrossRef
40.
Zurück zum Zitat Marild K, Ye W, Lebwohl B, et al. (2013) Antibiotic exposure and the development of coeliac disease: a nationwide case–control study. BMC Gastroenterol 13(109):13–109 Marild K, Ye W, Lebwohl B, et al. (2013) Antibiotic exposure and the development of coeliac disease: a nationwide case–control study. BMC Gastroenterol 13(109):13–109
41.
Zurück zum Zitat Ludvigsson JF, Nordenvall C, Jarvholm B (2014) Smoking, use of moist snuff and risk of celiac disease: a prospective study. BMC Gastroenterol 14(120):14–120 Ludvigsson JF, Nordenvall C, Jarvholm B (2014) Smoking, use of moist snuff and risk of celiac disease: a prospective study. BMC Gastroenterol 14(120):14–120
42.
Zurück zum Zitat Patel AH, Loftus EV, Murray JA, et al. (2001) Cigarette smoking and celiac sprue: a case–control study. Am J Gastroenterol 96(8):2388–2391PubMedCrossRef Patel AH, Loftus EV, Murray JA, et al. (2001) Cigarette smoking and celiac sprue: a case–control study. Am J Gastroenterol 96(8):2388–2391PubMedCrossRef
43.
Zurück zum Zitat Binder HJ (2015) Disorders of absorption. In: Kasper D, Fauci A, Hauser S, Longo D, Jameson JL, Loscalzo J (eds) Harrison’s principles of internal medicine, 19th edn. New York: McGraw-Hill Education Binder HJ (2015) Disorders of absorption. In: Kasper D, Fauci A, Hauser S, Longo D, Jameson JL, Loscalzo J (eds) Harrison’s principles of internal medicine, 19th edn. New York: McGraw-Hill Education
44.
Zurück zum Zitat S G (1890) On the coeliac affection. St Bart Hosp Rep: 2417–2420 S G (1890) On the coeliac affection. St Bart Hosp Rep: 2417–2420
48.
Zurück zum Zitat Skowera A, Peakman M, Cleare A, et al. (2001) High prevalence of serum markers of coeliac disease in patients with chronic fatigue syndrome. J Clin Pathol 54(4):335–336PubMedPubMedCentralCrossRef Skowera A, Peakman M, Cleare A, et al. (2001) High prevalence of serum markers of coeliac disease in patients with chronic fatigue syndrome. J Clin Pathol 54(4):335–336PubMedPubMedCentralCrossRef
49.
Zurück zum Zitat Sanders DS, Patel D, Stephenson TJ, et al. (2003) A primary care cross-sectional study of undiagnosed adult coeliac disease. Eur J Gastroenterol Hepatol 15(4):407–413PubMedCrossRef Sanders DS, Patel D, Stephenson TJ, et al. (2003) A primary care cross-sectional study of undiagnosed adult coeliac disease. Eur J Gastroenterol Hepatol 15(4):407–413PubMedCrossRef
51.
Zurück zum Zitat Hanif FM, Luck NH, Abbas Z, et al. (2015) Early, non-refractory celiac disease associated with microscopic colitis and splenomegaly. J Coll Phys Surg-Pakistan 25(Suppl 1):S14–S16 Hanif FM, Luck NH, Abbas Z, et al. (2015) Early, non-refractory celiac disease associated with microscopic colitis and splenomegaly. J Coll Phys Surg-Pakistan 25(Suppl 1):S14–S16
52.
Zurück zum Zitat Sadr-Azodi O, Sanders DS, Murray JA, Ludvigsson JF (2012) Patients with celiac disease have an increased risk for pancreatitis. Clin Gastroenterol Hepatol 10(10):1136–1142PubMedPubMedCentralCrossRef Sadr-Azodi O, Sanders DS, Murray JA, Ludvigsson JF (2012) Patients with celiac disease have an increased risk for pancreatitis. Clin Gastroenterol Hepatol 10(10):1136–1142PubMedPubMedCentralCrossRef
53.
Zurück zum Zitat Briggs JH, McKean D, Palmer JS, Bungay H (2014) Transient small bowel intussusception in adults: an overlooked feature of coeliac disease. BMJ Case Rep 20(10):2013–203156 Briggs JH, McKean D, Palmer JS, Bungay H (2014) Transient small bowel intussusception in adults: an overlooked feature of coeliac disease. BMJ Case Rep 20(10):2013–203156
55.
Zurück zum Zitat Collin P, Reunala T, Rasmussen M, et al. (1997) High incidence and prevalence of adult coeliac disease. Augmented diagnostic approach. Scand J Gastroenterol 32(11):1129–1133PubMedCrossRef Collin P, Reunala T, Rasmussen M, et al. (1997) High incidence and prevalence of adult coeliac disease. Augmented diagnostic approach. Scand J Gastroenterol 32(11):1129–1133PubMedCrossRef
65.
69.
Zurück zum Zitat Husby S, Koletzko S, Korponay-Szabo IR, et al. (2012) European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 54(1):136–160. doi:10.1097/MPG.0b013e31821a23d0 PubMedCrossRef Husby S, Koletzko S, Korponay-Szabo IR, et al. (2012) European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 54(1):136–160. doi:10.​1097/​MPG.​0b013e31821a23d0​ PubMedCrossRef
73.
Zurück zum Zitat Barker CC, Mitton C, Jevon G, Mock T (2005) Can tissue transglutaminase antibody titers replace small-bowel biopsy to diagnose celiac disease in select pediatric populations? Pediatrics 115(5):1341–1346. doi:10.1542/peds.2004-1392 PubMedCrossRef Barker CC, Mitton C, Jevon G, Mock T (2005) Can tissue transglutaminase antibody titers replace small-bowel biopsy to diagnose celiac disease in select pediatric populations? Pediatrics 115(5):1341–1346. doi:10.​1542/​peds.​2004-1392 PubMedCrossRef
75.
Zurück zum Zitat Donaldson MR, Book LS, Leiferman KM, Zone JJ, Neuhausen SL (2008) Strongly positive tissue transglutaminase antibodies are associated with Marsh 3 histopathology in adult and pediatric celiac disease. J Clin Gastroenterol 42(3):256–260. doi:10.1097/MCG.0b013e31802e70b1 PubMed Donaldson MR, Book LS, Leiferman KM, Zone JJ, Neuhausen SL (2008) Strongly positive tissue transglutaminase antibodies are associated with Marsh 3 histopathology in adult and pediatric celiac disease. J Clin Gastroenterol 42(3):256–260. doi:10.​1097/​MCG.​0b013e31802e70b1​ PubMed
76.
Zurück zum Zitat Trovato CM, Montuori M, Anania C, et al. (2015) Are ESPGHAN “biopsy-sparing” guidelines for celiac disease also suitable for asymptomatic patients? Am J Gastroenterol 110(10):1485–1489. doi:10.1038/ajg.2015.285 PubMedCrossRef Trovato CM, Montuori M, Anania C, et al. (2015) Are ESPGHAN “biopsy-sparing” guidelines for celiac disease also suitable for asymptomatic patients? Am J Gastroenterol 110(10):1485–1489. doi:10.​1038/​ajg.​2015.​285 PubMedCrossRef
77.
Zurück zum Zitat Saginur M, AlRefaee FAM, Spady DW, et al. (2013) Antitissue transglutaminase antibody determination versus upper endoscopic biopsy diagnosis of paediatric celiac disease. Paediatr Child Health 18(5):246–250 Saginur M, AlRefaee FAM, Spady DW, et al. (2013) Antitissue transglutaminase antibody determination versus upper endoscopic biopsy diagnosis of paediatric celiac disease. Paediatr Child Health 18(5):246–250
86.
Zurück zum Zitat Pham-Short A, Donaghue KC, Ambler G, et al. (2015) Screening for celiac disease in type 1 diabetes: a systematic review. Pediatrics 136(1):e170–e176PubMedCrossRef Pham-Short A, Donaghue KC, Ambler G, et al. (2015) Screening for celiac disease in type 1 diabetes: a systematic review. Pediatrics 136(1):e170–e176PubMedCrossRef
87.
Zurück zum Zitat Hadithi M, de Boer H, Meijer JW, et al. (2007) Coeliac disease in Dutch patients with Hashimoto’s thyroiditis and vice versa. World J Gastroenterol 13(11):1715–1722PubMedPubMedCentralCrossRef Hadithi M, de Boer H, Meijer JW, et al. (2007) Coeliac disease in Dutch patients with Hashimoto’s thyroiditis and vice versa. World J Gastroenterol 13(11):1715–1722PubMedPubMedCentralCrossRef
89.
Zurück zum Zitat Ansaldi N, Palmas T, Corrias A, et al. (2003) Autoimmune thyroid disease and celiac disease in children. J Pediatr Gastroenterol Nutr 37(1):63–66PubMedCrossRef Ansaldi N, Palmas T, Corrias A, et al. (2003) Autoimmune thyroid disease and celiac disease in children. J Pediatr Gastroenterol Nutr 37(1):63–66PubMedCrossRef
91.
Zurück zum Zitat Meloni A, Mandas C, Jores RD, Congia M (2009) Prevalence of autoimmune thyroiditis in children with celiac disease and effect of gluten withdrawal. J Pediatr 155(1):51–55, 55.e51. doi:10.1016/j.jpeds.2009.01.013 Meloni A, Mandas C, Jores RD, Congia M (2009) Prevalence of autoimmune thyroiditis in children with celiac disease and effect of gluten withdrawal. J Pediatr 155(1):51–55, 55.e51. doi:10.​1016/​j.​jpeds.​2009.​01.​013
92.
Zurück zum Zitat Kingham JG, Parker DR (1998) The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences. Gut 42(1):120–122PubMedPubMedCentralCrossRef Kingham JG, Parker DR (1998) The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences. Gut 42(1):120–122PubMedPubMedCentralCrossRef
93.
Zurück zum Zitat Floreani A, Betterle C, Baragiotta A, et al. (2002) Prevalence of coeliac disease in primary biliary cirrhosis and of antimitochondrial antibodies in adult coeliac disease patients in Italy. Dig Liver Dis 34(4):258–261PubMedCrossRef Floreani A, Betterle C, Baragiotta A, et al. (2002) Prevalence of coeliac disease in primary biliary cirrhosis and of antimitochondrial antibodies in adult coeliac disease patients in Italy. Dig Liver Dis 34(4):258–261PubMedCrossRef
98.
Zurück zum Zitat Catassi C, Rossini M, Rätsch IM, et al. (1993) Dose dependent effects of protracted ingestion of small amounts of gliadin in coeliac disease children: a clinical and jejunal morphometric study. Gut 34(11):1515–1519PubMedPubMedCentralCrossRef Catassi C, Rossini M, Rätsch IM, et al. (1993) Dose dependent effects of protracted ingestion of small amounts of gliadin in coeliac disease children: a clinical and jejunal morphometric study. Gut 34(11):1515–1519PubMedPubMedCentralCrossRef
99.
Zurück zum Zitat Catassi C, Fabiani E, Iacono G, et al. (2007) A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. Am J Clin Nutr 85(1):160–166PubMed Catassi C, Fabiani E, Iacono G, et al. (2007) A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. Am J Clin Nutr 85(1):160–166PubMed
100.
Zurück zum Zitat Standard for Foods for Special Dietary Use for Persons Intolerant to Gluten. Codex Committee on Nutrition and Foods for Special Dietary Uses, vol Adopted in 1979. Amendment: 1983 and 2015. Revision: 2008. Standard for Foods for Special Dietary Use for Persons Intolerant to Gluten. Codex Committee on Nutrition and Foods for Special Dietary Uses, vol Adopted in 1979. Amendment: 1983 and 2015. Revision: 2008.
101.
102.
Zurück zum Zitat Sey MS, Parfitt J, Gregor J (2011) Prospective study of clinical and histological safety of pure and uncontaminated Canadian oats in the management of celiac disease. JPEN J Parenter Enteral Nutr 35(4):459–464. doi:10.1177/0148607110387800 PubMedCrossRef Sey MS, Parfitt J, Gregor J (2011) Prospective study of clinical and histological safety of pure and uncontaminated Canadian oats in the management of celiac disease. JPEN J Parenter Enteral Nutr 35(4):459–464. doi:10.​1177/​0148607110387800​ PubMedCrossRef
103.
Zurück zum Zitat Kemppainen TA, Heikkinen MT, Ristikankare MK, Kosma VM, Julkunen RJ (2010) Nutrient intakes during diets including unkilned and large amounts of oats in celiac disease. Eur J Clin Nutr 64(1):62–67. doi:10.1038/ejcn.2009.113 PubMedCrossRef Kemppainen TA, Heikkinen MT, Ristikankare MK, Kosma VM, Julkunen RJ (2010) Nutrient intakes during diets including unkilned and large amounts of oats in celiac disease. Eur J Clin Nutr 64(1):62–67. doi:10.​1038/​ejcn.​2009.​113 PubMedCrossRef
105.
Zurück zum Zitat Pink IJ, Creamer B (1967) Response to a gluten-free diet of patients with the coeliac syndrome. Lancet 1(7485):300–304PubMedCrossRef Pink IJ, Creamer B (1967) Response to a gluten-free diet of patients with the coeliac syndrome. Lancet 1(7485):300–304PubMedCrossRef
107.
Zurück zum Zitat Leffler DA, Dennis M, Hyett B, et al. (2007) Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol 5(4):445–450PubMedCrossRef Leffler DA, Dennis M, Hyett B, et al. (2007) Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol 5(4):445–450PubMedCrossRef
108.
Zurück zum Zitat O’Mahony S, Howdle PD, Losowsky MS (1996) Review article: management of patients with non-responsive coeliac disease. Aliment Pharmacol Ther 10(5):671–680PubMedCrossRef O’Mahony S, Howdle PD, Losowsky MS (1996) Review article: management of patients with non-responsive coeliac disease. Aliment Pharmacol Ther 10(5):671–680PubMedCrossRef
109.
Zurück zum Zitat Abdulkarim AS, Burgart LJ, See J, Murray JA (2002) Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol 97(8):2016–2021PubMedCrossRef Abdulkarim AS, Burgart LJ, See J, Murray JA (2002) Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol 97(8):2016–2021PubMedCrossRef
110.
Zurück zum Zitat van Gils T, Nijeboer P, van Wanrooij RL, Bouma G, Mulder CJ (2015) Mechanisms and management of refractory coeliac disease. Nat Rev Gastroenterol Hepatol 12(10):572–579PubMedCrossRef van Gils T, Nijeboer P, van Wanrooij RL, Bouma G, Mulder CJ (2015) Mechanisms and management of refractory coeliac disease. Nat Rev Gastroenterol Hepatol 12(10):572–579PubMedCrossRef
111.
Zurück zum Zitat Roshan B, Leffler DA, Jamma S, et al. (2011) The incidence and clinical spectrum of refractory celiac disease in a north american referral center. Am J Gastroenterol 106(5):923–928PubMedCrossRef Roshan B, Leffler DA, Jamma S, et al. (2011) The incidence and clinical spectrum of refractory celiac disease in a north american referral center. Am J Gastroenterol 106(5):923–928PubMedCrossRef
113.
Zurück zum Zitat Malamut G, Afchain P, Verkarre V, et al. (2009) Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology 136(1):81–90PubMedCrossRef Malamut G, Afchain P, Verkarre V, et al. (2009) Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology 136(1):81–90PubMedCrossRef
114.
Zurück zum Zitat Rubio-Tapia A, Kelly DG, Lahr BD, et al. (2009) Clinical staging and survival in refractory celiac disease: a single center experience. Gastroenterology 136(1):99–107PubMedCrossRef Rubio-Tapia A, Kelly DG, Lahr BD, et al. (2009) Clinical staging and survival in refractory celiac disease: a single center experience. Gastroenterology 136(1):99–107PubMedCrossRef
115.
Zurück zum Zitat Al-Toma A, Verbeek WH, Hadithi M, von Blomberg BM, Mulder CJ (2007) Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut 56(10):1373–1378PubMedPubMedCentralCrossRef Al-Toma A, Verbeek WH, Hadithi M, von Blomberg BM, Mulder CJ (2007) Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut 56(10):1373–1378PubMedPubMedCentralCrossRef
116.
Zurück zum Zitat Delabie J, Holte H, Vose JM, et al. (2011) Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. Blood 118(1):148–155PubMedCrossRef Delabie J, Holte H, Vose JM, et al. (2011) Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. Blood 118(1):148–155PubMedCrossRef
117.
Zurück zum Zitat Sieniawski M, Angamuthu N, Boyd K, et al. (2010) Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation. Blood 115(18):3664–3670PubMedCrossRef Sieniawski M, Angamuthu N, Boyd K, et al. (2010) Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation. Blood 115(18):3664–3670PubMedCrossRef
118.
119.
Zurück zum Zitat Askling J, Linet M, Gridley G, et al. (2002) Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology 123(5):1428–1435PubMedCrossRef Askling J, Linet M, Gridley G, et al. (2002) Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology 123(5):1428–1435PubMedCrossRef
120.
Zurück zum Zitat Brousse N, Meijer JW (2005) Malignant complications of coeliac disease. Best Pract Res Clin Gastroenterol 19(3):401–412PubMedCrossRef Brousse N, Meijer JW (2005) Malignant complications of coeliac disease. Best Pract Res Clin Gastroenterol 19(3):401–412PubMedCrossRef
121.
Zurück zum Zitat Zar N, Holmberg L, Wilander E, Rastad J (1996) Survival in small intestinal adenocarcinoma. Eur J Cancer 12(9):2114–2119CrossRef Zar N, Holmberg L, Wilander E, Rastad J (1996) Survival in small intestinal adenocarcinoma. Eur J Cancer 12(9):2114–2119CrossRef
123.
Zurück zum Zitat Castillo NE, Vanga RR, Theethira TG, et al. (2015) Prevalence of abnormal liver function tests in celiac disease and the effect of a gluten-free diet in the US population. Am J Gastroenterol 110(8):1216–1222. doi:10.1038/ajg.2015.192 PubMedCrossRef Castillo NE, Vanga RR, Theethira TG, et al. (2015) Prevalence of abnormal liver function tests in celiac disease and the effect of a gluten-free diet in the US population. Am J Gastroenterol 110(8):1216–1222. doi:10.​1038/​ajg.​2015.​192 PubMedCrossRef
134.
Zurück zum Zitat Rutherford RM, Brutsche MH, Kearns M, et al. (2004) Prevalence of coeliac disease in patients with sarcoidosis. Eur J Gastroenterol Hepatol 16(9):911–915PubMedCrossRef Rutherford RM, Brutsche MH, Kearns M, et al. (2004) Prevalence of coeliac disease in patients with sarcoidosis. Eur J Gastroenterol Hepatol 16(9):911–915PubMedCrossRef
136.
Zurück zum Zitat Sorensen HT, Thulstrup AM, Blomqvist P, et al. (1999) Risk of primary biliary liver cirrhosis in patients with coeliac disease: Danish and Swedish cohort data. Gut 44(5):736–738PubMedPubMedCentralCrossRef Sorensen HT, Thulstrup AM, Blomqvist P, et al. (1999) Risk of primary biliary liver cirrhosis in patients with coeliac disease: Danish and Swedish cohort data. Gut 44(5):736–738PubMedPubMedCentralCrossRef
145.
Metadaten
Titel
Celiac disease: a clinical review
verfasst von
Badr Al-Bawardy
D. Chamil Codipilly
Alberto Rubio-Tapia
David H. Bruining
Stephanie L. Hansel
Joseph A. Murray
Publikationsdatum
12.01.2017
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 2/2017
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-1034-y

Weitere Artikel der Ausgabe 2/2017

Abdominal Radiology 2/2017 Zur Ausgabe

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Wie toxische Männlichkeit der Gesundheit von Männern schadet

08.04.2024 Andrologie Nachrichten

Stark, erfolgreich, allzeit belastbar – das sind Erwartungen, die Jungen und Männer von der Gesellschaft spüren. Das kann sie „toxisch“ werden lassen – und letztlich sogar der Gesundheit schaden, mahnt Dr. Dirk Sander von der Deutschen Aidshilfe.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.